14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 ALXO stock ended at $15.36. This is 7.58% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 12.59% from a day low at $15.21 to a day high of $17.13.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical ALX Oncology Holdings Inc. prices

Date Open High Low Close Volume
Oct 05, 2020 $34.99 $35.89 $33.00 $34.79 113 244
Oct 02, 2020 $33.54 $35.46 $32.51 $34.63 101 977
Oct 01, 2020 $37.78 $38.12 $33.37 $34.11 548 781
Sep 30, 2020 $38.37 $38.97 $36.37 $37.74 84 590
Sep 29, 2020 $39.68 $42.34 $37.78 $38.26 83 082
Sep 28, 2020 $39.37 $41.50 $39.00 $39.78 83 342
Sep 25, 2020 $39.29 $40.60 $37.71 $39.07 80 242
Sep 24, 2020 $39.20 $39.47 $36.66 $39.22 136 898
Sep 23, 2020 $37.05 $39.97 $36.42 $39.29 97 361
Sep 22, 2020 $37.68 $38.70 $36.29 $37.08 218 828
Sep 21, 2020 $37.00 $37.74 $34.19 $37.14 213 810
Sep 18, 2020 $38.56 $39.93 $36.51 $37.36 1 623 884
Sep 17, 2020 $39.52 $40.23 $38.02 $38.22 246 343
Sep 16, 2020 $39.56 $41.45 $39.00 $39.74 408 035
Sep 15, 2020 $39.62 $43.84 $38.12 $39.06 126 654
Sep 14, 2020 $39.89 $41.81 $38.14 $39.24 109 227
Sep 11, 2020 $40.54 $42.79 $37.43 $39.43 90 496
Sep 10, 2020 $43.46 $44.49 $39.57 $40.35 90 103
Sep 09, 2020 $44.41 $48.20 $42.40 $42.56 129 224
Sep 08, 2020 $42.50 $44.70 $41.58 $43.84 116 229
Sep 04, 2020 $41.49 $44.50 $41.49 $42.99 64 340
Sep 03, 2020 $44.16 $44.20 $41.33 $41.70 53 997
Sep 02, 2020 $41.69 $45.45 $41.10 $44.16 68 800
Sep 01, 2020 $40.34 $43.44 $39.08 $41.75 90 514
Aug 31, 2020 $44.59 $47.57 $38.12 $40.44 193 831
Click to get the best stock tips daily for free!

About ALX Oncology Holdings Inc.

ALX Oncology Holdings. ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin's lymphoma, as well as a range of solid tumor indications, including head and neck squamous cell c... ALXO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT